SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Chiò Adriano) ;lar1:(ki)"

Sökning: WFRF:(Chiò Adriano) > Karolinska Institutet

  • Resultat 1-3 av 3
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Al-Chalabi, Ammar, et al. (författare)
  • July 2017 ENCALS statement on edaravone
  • 2017
  • Ingår i: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. - : TAYLOR & FRANCIS LTD. - 2167-8421 .- 2167-9223. ; 18:7-8, s. 471-474
  • Tidskriftsartikel (refereegranskat)abstract
    • n/a
  •  
2.
  • Dewan, Ramita, et al. (författare)
  • Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
  • 2021
  • Ingår i: Neuron. - : Elsevier BV. - 1097-4199 .- 0896-6273. ; 109:3
  • Tidskriftsartikel (refereegranskat)abstract
    • We examined the role of repeat expansions in the pathogenesis of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) by analyzing whole-genome sequence data from 2,442 FTD/ALS patients, 2,599 Lewy body dementia (LBD) patients, and 3,158 neurologically healthy subjects. Pathogenic expansions (range, 40-64 CAG repeats) in the huntingtin (HTT) gene were found in three (0.12%) patients diagnosed with pure FTD/ALS syndromes but were not present in the LBD or healthy cohorts. We replicated our findings in an independent collection of 3,674 FTD/ALS patients. Postmortem evaluations of two patients revealed the classical TDP-43 pathology of FTD/ALS, as well as huntingtin-positive, ubiquitin-positive aggregates in the frontal cortex. The neostriatal atrophy that pathologically defines Huntington's disease was absent in both cases. Our findings reveal an etiological relationship between HTT repeat expansions and FTD/ALS syndromes and indicate that genetic screening of FTD/ALS patients for HTT repeat expansions should be considered.
  •  
3.
  • Kliest, Tessa, et al. (författare)
  • Clinical trials in pediatric ALS: a TRICALS feasibility study
  • 2022
  • Ingår i: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. - : Taylor & Francis Group. - 2167-8421 .- 2167-9223. ; 23:7-8, s. 481-488
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Pediatric investigation plans (PIPs) describe how adult drugs can be studied in children. In 2015, PIPs for Amyotrophic Lateral Sclerosis (ALS) became mandatory for European marketing-authorization of adult treatments, unless a waiver is granted by the European Medicines Agency (EMA).Objective: To assess the feasibility of clinical studies on the effect of therapy in children (<18 years) with ALS in Europe.Methods: The EMA database was searched for submitted PIPs in ALS. A questionnaire was sent to 58 European ALS centers to collect the prevalence of pediatric ALS during the past ten years, the recruitment potential for future pediatric trials, and opinions of ALS experts concerning a waiver for ALS.Results: Four PIPs were identified; two were waived and two are planned for the future. In total, 49 (84.5%) centers responded to the questionnaire. The diagnosis of 44,858 patients with ALS was reported by 46 sites; 39 of the patients had an onset < 18 years (prevalence of 0.008 cases per 100,000 or 0.087% of all diagnosed patients). The estimated recruitment potential (47 sites) was 26 pediatric patients within five years. A majority of ALS experts (75.5%) recommend a waiver should apply for ALS due to the low prevalence of pediatric ALS.Conclusions: ALS with an onset before 18 years is extremely rare and may be a distinct entity from adult ALS. Conducting studies on the effect of disease-modifying therapy in pediatric ALS may involve lengthy recruitment periods, high costs, ethical/legal implications, challenges in trial design and limited information.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-3 av 3
Typ av publikation
tidskriftsartikel (3)
Typ av innehåll
refereegranskat (3)
Författare/redaktör
Chio, Adriano (3)
Al-Chalabi, Ammar (2)
van Damme, Philip (2)
Corcia, Philippe (2)
Couratier, Philippe (2)
Hardiman, Orla (2)
visa fler...
Silani, Vincenzo (2)
van den Berg, Leonar ... (2)
de Carvalho, Mamede (2)
Weber, Markus (2)
Desnuelle, Claude (2)
Grosskreutz, Julian (2)
Ingre, Caroline (2)
Koritnik, Blaz (2)
Meyer, Thomas (2)
Petri, Susanne (2)
Salachas, Francois (2)
Svenstrup, Kirsten (2)
Andersen, Peter M. (1)
Povedano Panades, Mó ... (1)
Andersen, Peter M., ... (1)
Landers, John E. (1)
Glass, Jonathan D. (1)
Camu, William (1)
Talbot, Kevin (1)
Keagle, Pamela (1)
Chandran, Siddhartha ... (1)
Danielsson, Olof (1)
Grehl, Torsten (1)
Holmoy, Trygve (1)
Karlsborg, Merete (1)
Kleveland, Grethe (1)
Christoph Koch, Jan (1)
KuzmaKozakiewicz, Ma ... (1)
Laaksovirta, Hannu (1)
Ludolph, Albert (1)
McDermott, Christoph ... (1)
Mitre Ropero, Bernar ... (1)
Mora Pardina, Jesus (1)
Nygren, Ingela (1)
Shaw, Pamela (1)
Staaf, Gert (1)
Tysnes, Ole-Bjorn (1)
van der Kooi, Anneke (1)
Weydt, Patrick (1)
Wolf, Joachim (1)
Tagliavini, Fabrizio (1)
Albanese, Alberto (1)
Johansson, Per, 1966 (1)
Stein, Thor D (1)
visa färre...
Lärosäte
Karolinska Institutet  (3)Ta bort avgränsningen
Umeå universitet (2)
Lunds universitet (2)
Göteborgs universitet (1)
Uppsala universitet (1)
Linköpings universitet (1)
Språk
Engelska (3)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (3)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy